Vascular Closure Devices Market Size to Rise USD 3.30 Bn by 2033

The global vascular closure devices market is predicted to reach around USD 3.30 billion by 2033, growing at a CAGR of 6.55% from 2024 to 2033.

Key Points

  • North America led the market with the biggest market share of 43% in 2023.
  • Asia Pacific is observed to witness the fastest rate of expansion during the forecast period.
  • By type, the active vascular closure devices segment held the largest share of the market in 2023.
  • By access, the femoral segment is expected to capture a prominent market share during the forecast period while sustaining dominance.
  • By end-use, the ambulatory surgical centers segment dominated the market with the largest share of 61% in 2023.

Vascular Closure Devices Market Size 2024 to 2033

The Vascular Closure Devices (VCD) market is witnessing significant growth due to the rising prevalence of cardiovascular diseases and the increasing demand for minimally invasive procedures. VCDs play a crucial role in sealing puncture sites created during catheterization procedures, thereby reducing bleeding complications and improving patient outcomes. The market encompasses a diverse range of devices designed to cater to various vascular closure needs, including femoral artery closures and others.

The global Vascular Closure Devices market has experienced a substantial boost in recent years, driven by advancements in technology, increased awareness about cardiovascular health, and a growing aging population. As healthcare systems strive for more efficient and patient-friendly solutions, VCDs have gained prominence for their ability to facilitate quicker recovery, reduced hospital stays, and enhanced overall procedural outcomes.

Get a Sample:

Growth Factors:

Several factors contribute to the growth of the Vascular Closure Devices market. Technological innovations, such as the development of next-generation closure devices with improved safety profiles and ease of use, are key growth drivers. The shift towards minimally invasive procedures, driven by patient preferences and the potential for quicker recovery, has fueled the demand for VCDs.

Moreover, the increasing incidence of cardiovascular diseases globally has created a substantial market base for vascular closure devices. As healthcare providers focus on preventive and interventional cardiology, the demand for reliable and efficient closure devices continues to rise. The integration of advanced materials in device manufacturing, coupled with the emphasis on user-friendly designs, further propels market growth.

Vascular Closure Devices Market Scope

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 6.55%
Global Market Size in 2023 USD 1.75 Billion
Global Market Size by 2033 USD 3.30 Billion
U.S. Market Size in 2023 USD 530 Million
U.S. Market Size by 2033 USD 990 Million
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Type, By Access, and By End-use
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Vascular Closure Devices Market Dynamics


The Vascular Closure Devices market is primarily driven by the growing number of catheterization procedures and interventions, particularly in the field of cardiology. The rise in percutaneous coronary interventions (PCIs) and other vascular interventions has increased the demand for reliable closure solutions to manage access site complications effectively.

Additionally, the emphasis on reducing hospital stays and promoting outpatient care has driven the adoption of vascular closure devices. Hospitals and healthcare providers are increasingly recognizing the economic benefits associated with quicker patient recovery and reduced post-procedural complications, further boosting the market growth.


Despite the positive momentum, the Vascular Closure Devices market faces certain challenges. One significant restraint is the presence of alternative closure methods, such as manual compression, which remains a widely practiced technique in many healthcare settings. The cost associated with VCDs may act as a deterrent for widespread adoption, particularly in regions with budget constraints in healthcare expenditures.

Concerns regarding potential complications, such as vascular complications and device-related issues, may also hinder market growth. Achieving a balance between the benefits and risks associated with VCDs remains a key challenge for manufacturers and healthcare professionals alike.


The Vascular Closure Devices market presents lucrative opportunities for industry players to invest in research and development, focusing on creating more advanced and safer devices. Emerging markets with a rising prevalence of cardiovascular diseases offer untapped potential for market expansion. Strategic collaborations and partnerships between manufacturers and healthcare institutions can facilitate the introduction of innovative solutions and enhance market penetration.

Furthermore, the increasing trend of outpatient procedures and ambulatory care settings opens up opportunities for the integration of VCDs into a broader spectrum of healthcare services. Educating healthcare professionals about the advantages of VCDs and addressing concerns related to their usage can contribute to the wider adoption of these devices.

Read Also: Tubeless Insulin Pump Market Size to Attain USD 11.93 Bn by 2033

Region Insights:

The Vascular Closure Devices market exhibits regional variations influenced by healthcare infrastructure, economic conditions, and disease prevalence. North America and Europe, with their well-established healthcare systems, dominate the market. The Asia-Pacific region, driven by the growing healthcare expenditure and rising awareness about cardiovascular health, is expected to witness substantial growth.

In North America, the United States holds a significant market share, owing to the high prevalence of cardiovascular diseases and the presence of leading industry players. European countries, such as Germany and the United Kingdom, follow closely, with increased adoption of advanced medical technologies.

The Asia-Pacific region, particularly China and India, presents a burgeoning market for Vascular Closure Devices. The rising geriatric population, changing lifestyle patterns, and improving healthcare infrastructure contribute to the market’s expansion in this region.

Recent Developments

  • In February 2023, the LockeT product was introduced to the market by Catheter Precision, Inc., a wholly-owned subsidiary of Ra Medical Systems, Inc. The first shipments of the product to its distributors will start right away. When a catheter is inserted through the skin into a blood artery and subsequently removed after an operation, LockeT can be utilized in combination with the closure of the percutaneous wound site. LockeT is used to keep the sutures in place after the doctor has sutured the vessel and the location. The lockeT can be utilized in place of or in addition to closing devices. These devices are Angioseal, marketed by Terumo, Vascade, marketed by Cardiva, a division of Haemonetics, and Perclose, marketed by Abbott.

Vascular Closure Devices Market Companies

  • Medtronic
  • Abbott Vascular
  • Biotronik GMBH & CO. KG
  • COOK
  • Merit Medical Systems, Inc.
  • C. R. Bard, Inc.
  • Boston Scientific Corporation
  • Cardinal Health
  • W L. Gore & Associates

Segments Covered in the Report

By Type

  • Active Vascular Closure Device
  • Passive Vascular Closure Device

By Access

  • Radial
  • Femoral

By End-use

  • Ambulatory Surgical Centers
  • Hospitals
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa



I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.


I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Prathamesh →

Leave a Reply

Your email address will not be published. Required fields are marked *